Published in J Urol on February 01, 2006
In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol (2005) 3.92
Formalin disinfection of biopsy needle minimizes the risk of sepsis following prostate biopsy. J Urol (2013) 2.81
XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology (2010) 2.55
Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat Protoc (2007) 2.45
Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate (2005) 2.19
North American white mitochondrial haplogroups in prostate and renal cancer. J Urol (2006) 2.13
Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. Cancer Res (2006) 2.05
Epididymal sparing bilateral simple orchiectomy with epididymoplasty: preservation of esthetics and body image. J Urol (2005) 1.54
Molecular classification of renal tumors by gene expression profiling. J Mol Diagn (2005) 1.52
Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots. ACS Nano (2010) 1.31
Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy. Am J Pathol (2011) 1.24
Loss of HOXC6 expression induces apoptosis in prostate cancer cells. Oncogene (2005) 1.23
Oxidative stress induces ADAM9 protein expression in human prostate cancer cells. Cancer Res (2006) 1.23
Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. Lab Invest (2003) 1.22
Role of transrectal ultrasonography in diagnosis and treatment of retained Foley catheter. Urology (2005) 1.21
Spermatic cord anesthesia block for scrotal procedures in outpatient clinic setting. J Urol (2004) 1.20
PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer. Cancer Res (2004) 1.15
Dilutional hyponatremia of TURP syndrome: a historical event in the 21st century. Urology (2004) 1.09
Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am J Surg Pathol (2003) 1.05
Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res Treat (2009) 1.05
Thrombocytosis is associated with a significant increase in the cancer specific death rate after radical nephrectomy. J Urol (2002) 1.05
Pelvic nephroureterectomy for renal cell carcinoma in an ectopic kidney. Case Rep Oncol Med (2012) 1.02
Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment. Prostate (2009) 1.01
Endoscopic enucleation of leiomyoma of the bladder. Urol Int (2005) 0.97
Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men. Prostate (2009) 0.92
Radical prostatectomy for clinical T4 prostate cancer. Cancer (2006) 0.89
Current trends in molecular classification of adult renal tumors. Urology (2006) 0.88
Increased low density lipoprotein and increased likelihood of positive prostate biopsy in black americans. J Urol (2009) 0.88
Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1. Am J Pathol (2007) 0.87
The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsy. Cancer Detect Prev (2006) 0.84
An inherited heteroplasmic mutation in mitochondrial gene COI in a patient with prostate cancer alters reactive oxygen, reactive nitrogen and proliferation. Biomed Res Int (2012) 0.82
Mitochondrial genotype and breast cancer predisposition. Oncol Rep (2010) 0.82
The fate of the medically castrated testis: expectation versus reality. J Urol (2004) 0.81
Mitochondrial NADH-dehydrogenase polymorphisms as sporadic breast cancer risk factor. Oncol Rep (2010) 0.81
Surgical margin and Gleason score as predictors of postoperative recurrence in prostate cancer with or without chromosome 8p allelic imbalance. Prostate (2004) 0.81
Mitochondrial Cytochrome c Oxidase subunit 1 Sequence Variation in Prostate Cancer. Scientifica (Cairo) (2012) 0.80
Comparison of 12-core versus 8-core prostate biopsy: multivariate analysis of large series of US veterans. Urology (2011) 0.79
Automated sequencing of complete mitochondrial genomes from laser-capture microdissected samples. Biotechniques (2003) 0.77
Embryonic stem-cell research. N Engl J Med (2004) 0.75
Pulsatile mass in the scrotum in a man with the Leriche syndrome. J Urol (2002) 0.75
A +20% adjustment in the computed tomography measured ureteral length is an accurate predictor of true ureteral length before ureteral stent placement. J Endourol (2013) 0.75